Table II-2. Enhanced Contrast/Bolus Module Attribute Mapping
|
Enhanced Contrast/Bolus Module Attribute Name |
Tag |
Product Characteristics Module Source |
|---|---|---|
|
Contrast/Bolus Agent Sequence |
(0018,0012) |
-- |
|
>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3 |
Product Type Code Sequence (0044,0007) > 'Code Sequence Macro' |
|
|
>Contrast/Bolus Agent Number |
(0018,9337) |
|
|
>Contrast/Bolus Administration Route Sequence |
(0018,0014) |
|
|
>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3 |
||
|
>Contrast/Bolus Ingredient Code Sequence |
(0018,9338) |
-- |
|
>>Include Table 8.8-1 “Code Sequence Macro Attributes” in PS3.3 |
Product Parameter Sequence (0044,0013) > Concept Code Sequence (0040,A168), where:
|
|
|
>Contrast/Bolus Volume |
(0018,1041) |
If contrast is administered without dilution, and using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where:
|
|
>Contrast/Bolus Ingredient Concentration |
(0018,1049) |
If contrast is administered without dilution: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where:
|
|
>Contrast/Bolus Ingredient Opaque |
(0018,9425) |
Product Parameter Sequence (0044,0013) > Concept Code Sequence (0040,A168) > Code Meaning (0008,0104), where:
|
|
>Contrast Administration Profile Sequence |
(0018,9340) |
|
|
>>Contrast/Bolus Volume |
(0018,1041) |
If contrast is administered without dilution, and using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where:
|
|
>>Contrast/Bolus Start Time |
(0018,1042) |
|
|
>>Contrast/Bolus Stop Time |
(0018,1043) |
|
|
>>Contrast Flow Rate |
(0018,1046) |
|
|
>>Contrast Flow Duration |
(0018,1047) |
|